Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Haematologia|February 24, 2001
Effects of a membrane-metallopeptidase blocking agent thiorphan in long-term cultures of human bone marrowS Stanović Janda, M Boranić, M Sucić, et al.Nuclear Medicine Communications|July 19, 2002
Bone marrow immunoscintigraphy in haematological patients with pancytopenia: preliminary resultsDrazen Huić, V Ivancević, I Aurer, et al.Haematologica|May 1, 1995
Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapyD Nemet, B Grahovac, B Labar, et al.Bone Marrow Transplantation|November 1, 1992
Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplantB Labar, V Bogdanić, D Nemet, et al.Bone Marrow Transplantation|May 1, 1993
Prostaglandin E2 for prophylaxis of oral mucositis following BMTB Labar, M Mrsić, Z Pavletić, et al.Journal of Chemotherapy (Florence, Italy)|December 4, 2008
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICEI Aurer, Z Mitrović, D Nemet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience)I Radman, N Basić, B Labar, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS riskM Spina, Z Nagy, J M Ribera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)A Younes, P Hilden, B Coiffier, et al.Pageof 2